SEC Filing Summary: Clover Health Investments, Corp. (CLOV)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Clover Health Investments, Corp. on October 31, 2025. The Company is a remote-first organization with no physical headquarters, operating under Delaware law. The report primarily addresses a change in corporate governance.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a personnel change and does not contain financial statements or performance data.
Material Changes
- Board Departure: Chelsea Clinton notified the Company of her intention to conclude her service as a member of the Board of Directors, the Talent and Compensation Committee, and the Nominating and Corporate Governance Committee effective October 31, 2025.
- Reason for Departure: The departure is not the result of any disagreement with the Company regarding operations, policies, or practices.
- Board Composition: The authorized number of directors remains at nine. Following Ms. Clinton's departure, the Board will operate with two vacant seats.
Outlook and Management Commentary
The Board intends to fill the vacancy created by Ms. Clinton's departure as soon as practicable. No specific guidance, risk factors, or unusual items were disclosed in this filing.
Key Facts for Investor Verification
- Confirm the timeline for the appointment of a new director to fill the vacancy.
- Verify if the departure of a board member impacts the quorum or voting dynamics of the Talent and Compensation or Nominating and Corporate Governance Committees.
- Review the attached Press Release (Exhibit 99.1) for additional context not included in the 8-K text.